Pearl River Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,671
Closed -$315K 297
2024
Q2
$315K Buy
+7,671
New +$315K 0.05% 353
2021
Q2
Sell
-2,422
Closed -$276K 546
2021
Q1
$276K Sell
2,422
-922
-28% -$105K 0.09% 306
2020
Q4
$463K Sell
3,344
-2,488
-43% -$344K 0.17% 195
2020
Q3
$479K Buy
+5,832
New +$479K 0.2% 173
2020
Q2
Sell
-888
Closed -$39K 521
2020
Q1
$39K Buy
+888
New +$39K 0.08% 268
2019
Q1
Sell
-319
Closed -$14K 696
2018
Q4
$14K Buy
+319
New +$14K 0.06% 424